MNK99
Well-Known Member
- Messages
- 5,560
- Deleted by MNK99
-Just summarizing some info, while I await TEI results (next week). --> And hopefully I buy rec'd supplements from TEI or Goose12's selected place.
-Some Info from (used: Open Text Summarizer [splitbrain.org])
Trace elements in bipolar disorder. - NCBI
Trace elements in bipolar disorder. - PubMed - NCBI
by M González-Estecha - 2011 - Cited by 33 - Related articles
Jan 15, 2011 - INTRODUCTION: Trace elements may play an important role in bipolar disorders. The objective of this study is to determine serum copper and
And some Diabetes Study which mentions Lithium (and says not generalizable... weakly effective for treating DIABETES). I don't have that... but whatever, BP may also be "a metabolistic disorder"
Trace elements in glucometabolic disorders: an update | Diabetology & Metabolic Syndrome | Full Text
Journal of Trace Elements in Medicine and Biology
Volume 25, Supplement 1, January 2011, Pages S78-S83
Abstract
Trace elements may play an important role in bipolar disorders. The objective of this study is to determine serum copper and zinc, blood lead and cadmium and urine lead, cadmium and thallium concentrations in patients diagnosed with bipolar disorders and to compare these levels with those of a healthy control group. There was a statistically significant increase (p = 0.001) in zinc levels among patients in the manic phase (mean 111.28, SD: 33.36 μg/dL) with respect to the control group (mean 86.07, SD: 12.39 μg/dL). 2010
Published: 19 December 2010
Abstract
Many trace elements, among which metals, are indispensable for proper functioning of a myriad of biochemical reactions, more particularly as enzyme cofactors. This is particularly true for the vast set of processes involved in regulation of glucose homeostasis, being it in glucose metabolism itself or in hormonal control, especially insulin. The role and importance of trace elements such as chromium, zinc, selenium, lithium and vanadium are much less evident and subjected to chronic debate. A careful survey of the literature shows that while theoretical postulates from some key roles of these elements had led to real hopes for therapy of insulin resistance and diabetes, the limited experience based on available data indicates that beneficial effects and use of most of them are subjected to caution, given the narrow window between safe and unsafe doses. Clear therapeutic benefit in these pathologies is presently doubtful but some data indicate that these metals may have a clinical interest in patients presenting deficiencies in individual metal levels.
Keywords
Insulin Resistance
Amyotrophic Lateral Sclerosis
Insulin Receptor
Prediabetic State
Phosphotyrosine Phosphatase
Introduction
Many trace elements, among which metals, involved as cofactors in myriads of biochemical-especially-enzymatic reactions. A good example to illustrate their important contribution is magnesium: low magnesium levels have been associated with increased type 2 diabetes [1, 2], whereas controversy exists about the importance of hypomagnesaemia in prediabetic states [3].
Trace elements have been identified for long time as potential candidates for improving metabolic disorders like prediabetes [insulin resistance, obesity, metabolic syndrome] or diabetes. In parallel with increasing comprehension of cellular and biochemical mechanisms leading to-or aggravating- these metabolic disorders, identifying the cellular targets and sites of action of trace elements has reactivated interest in their therapeutic potential. Activation of insulin receptor signalling (chromium), antioxidant properties (selenium, zinc) or inhibition of phosphatases (vanadium) thus appeared promising in view of the key importance of these processes in glucose homeostasis and insulin sensitivity. Indeed insulin receptor/postreceptor signalling defects are considered to underlie glycemic dysregulation and insulin resistance, although the precise causal defects must still be unravelled [4, 5]. Moreover, these mechanisms may be involved in concert in the pathogenesis of insulin resistance and accompanying pathologies [9].
The present review updates our actual state of knowledge about those five trace elements (chromium, zinc, selenium, vanadium, lithium)which have a therapeutic potential in insulin resistance and diabetes, describing their mechanisms of action and their efficacy in both animal and human investigations.
Chromium
General aspects
The importance of chromium (Cr) for glucose metabolic regulation has been seen in clinical states of relatively severe Cr deficiency, characterized by impaired glucose tolerance, fasting hyperglycaemia and eventually lipid disorders [10, 11]. Severe deficiencies are mostly limited to parenteral nutrition but analysis of diet plans currently in use in United States reveals a lack of Cr in many diets, potentially linked to various chronic diseases..
Mechanisms of action
Several mechanistic studies showed improvements in insulin receptor/postreceptor signalling, leading to increased glucose transport by enhanced activity of the hormone-sensitive GLUT-4 transporters. These effects can be due to the receptor itself, its control mechanisms or its immediate environment in the cell membrane. Cr-picolinate was shown to induce various effects: increase in AMPKinase and p38 MAPkinase activities [20], increase in receptor phosphorylation [21] and increase in insulin receptor mRNA (in addition to mRNA for GLUT-4, glycogen synthase and UCP3)[22]. Increased synthesis of IGF receptors, able to functionally replace failing insulin receptors, was also described [23]. Changes in the environment of insulin receptors were shown as reductions in plasma membrane cholesterol [24, 25], leading to improved cytoskeletal functioning and enhanced insulin sensitivity. Decreases in TNFα [26, 27], resistin [28], interleukin-6, CRP [27] as well as increases in vitamin C or adiponectin [29] were all positive mechanisms to reduce insulin resistance by Cr.
Finally, one should mention that Cr can bind directly to insulin, in particular to insulin dimers [30], thereby possibly stabilizing the hormone structure and/or modifying its receptor binding. Interestingly the Cr binding to insulin receptors occurs on a sequence of 3 aminoacids which are identical to those described for GTF decades ago (see below).
Biological effects
The appearance of glucose intolerance or even fasting hyperglycaemia in demonstrated cases of Cr deficiency have rapidly led to investigations on the potential of Cr supplementation in insulin resistance and diabetes. Furthermore, diabetic patients have about 1/3 less Cr in various biological samples [31, 32, 33]. While it was shown that inorganic Cr was poorly active, Mertz and coworkers identified as early as 1955 a complex found in brewer's yeast, liver and kidney which was able to stimulate glucose transport in the presence-but not in absence- of insulin and which contained Cr. Its activity required insulin and was dependent on its Cr content, ideally 4 ions/molecule, while 8 ions/molecule revealed toxic [34, 35]. Replacement of Cr by other metals did not reproduce GTF biological activity. It increased insulin efficacy in adipocytes [35, 37] at relatively high concentrations but no effects was found in diabetic patients despite demonstrable increases in Cr content of various tissues [38]. Especially in vitro and in animals studies are usually performed with irrelevant concentrations of the active compound, leading to so-called "pharmacological" effects. In vitro many beneficial effects of Cr salts have been reported for insulin resistance or diabetes; Cr chloride increased glucose transport in fat and muscle cells as well as in cardiomyocytes [17, 25, 35]. Insulin resistance improved in high fat/low Cr diet-fed rats [43], in sucrose-fed rats [44], in Zucker diabetic fatty rats [29], in GK rats [45, 46], in JCR-LA corpulent rats [47] and in db/db mice [48].
In addition to positive effects on glucose and insulin metabolic profiles, some studies also reported reduction in triglycerides [37] and stimulation of β-oxidation [50]. Positive reports with Cr exist in type2 diabetics treated with sulfonylureas [51] or in combination with either biotin [52] or vitamins C and E [53]. It is likely that patient selection is cardinal [57] and that Cr supplementation is primarily of interest in patients suffering from clearcut Cr deficiency if the aim is to reduce hyperglycaemia [58] or as an adjuvant to already-existing treatment with oral antidiabetics.
Based on mechanistic hypotheses (see below) the best application might be insulin resistance (prediabetes, metabolic syndrome), although this is also controversial: reduction in insulin resistance was observed in diabetics [53, 59] but also in obese women suffering polycystic ovary syndrome [60]. Another study in metabolic syndrome found no effect, however [61].
Zinc
General aspects
Zinc (Zn) is an essential micronutrient which has an important role in the functioning of hundreds of enzymes [62], in insulin metabolism and acts as an efficient antioxidant [63, 64]. Consequently many observations relate to Zn deficiency, although clinical signs of deficiency are quite modest. Because Zn has no storage form, there is need for a constant supply and Zn availability to cells is particularly well regulated, albeit poorly understood [67, 68]. Zn absorption can be reduced by iron or inflammatory bowel diseases. It is transported across cell membranes via t....
Severe Zn deficiency is not frequent but concerns have nevertheless been raised about Zn levels in diabetic patients because of increased excretion due to polyuria. Whereas some studies have reported Zn deficiency in type 2 diabetes [31, 76, 77, 78], others failed to find significant differences with healthy subjects [79, 80]. In type 1 diabetes, Zn deficiency is expected to increase the pancreatic damage [81]. A recent report described reduced levels of Zn in obese, insulin resistant subjects [82]. Lower Zn plasma concentrations were found in type 2 diabetics but they were not related to glycemic status or diabetes duration or components of the metabolic syndrome [83]. Interestingly it was reported that diabetic have elevated levels of copper [78, 80] and it could be that copper is in fact linked to metabolic syndrome and diabetes [80, 84]. Nevertheless, reduced Zn levels in diabetics appear to be related to increased risk for coronary artery disease [77] and mortality [85].
Mechanisms of action
Several modes of action have been described to explain the improved action of insulin by Zn. It appears that Zn can have direct insulin-like effects, which may be due to inhibition of the important glycogen-regulating enzyme GSK3 [86]. Zn can also reduce cytokines such as IL-1β as well as NFκB [87, 88]. Zn induces metallothionein synthesis, whereby Zn may have indirect efficacy [87]. Finally it has been suggested that the important Zn concentrations for its action are the intracellular -rather than plasma- levels [89]. Because Zn controls metallothionein expression it is involved in cellular redox regulation [91, 92]. Oxidative stress can be corrected by dietary Zn as demonstrated by an elevation of hepatic antioxidant enzymes [93].
Biological effects
Despite the potential interest in Zn in diabetes only some investigations have been published (reviewed in 62). In animals Zn prevented the development of type 1 diabetes induced by alloxan or streptozotocin [87]. In a study on Zn restriction during pregnancy in rats, offsprings presented reduced body weight, increased fat mass and low lean mass and showed reduced insulin response to glucose challenge. In db/db mice Zn reduced hyperglycaemia and hyperinsulinaemia [98]. Administration of Zn for 3 months reduced proteinuria [99]. Zn restriction increased oxidative stress and the levels of isoprostanes [100], in line with antioxidant effects of Zn. Excessive Zn, on the other hand, increased metabolic syndrome in rats fed a high fat/sucrose diet [101];
High Zn slightly reduced the risk for type 2 diabetes in a prospective study performed in 8300 women and the effect was limited to the Zn-deficient subgroup [103]. In microalbuminuric type 2 diabetic patients Zn lowered homocysteine levels while increasing vitamin B12 and folate levels [105]. In obese, non-diabetic subjects insulin sensitivity was improved without changes in leptin levels [106]. However no preventive effect against diabetes development could be found in obese women [107]. Oxidative stress was reduced by Zn in healthy elderly subjects [108]. It increases the pancreatic insulin content and improves the glucose tolerance test [109]. Its levels are lower in obese human subcutaneous and visceral adipose tissue and liver, but interestingly does not appear to be related to insulin resistance [110]. Severe Se deficiency is rare, while reduced Se levels are seen in diabetics together with increased oxidative stress. In offsprings of diabetic patients Se correlates inversely with CRP and with insulin resistance if Se levels are below 80 μg/l [118].
Biological effects
In view of the potent antioxidant [122, 123] and anti-inflammatory effects of Se and the prominent role played by these disorders in insulin resistance and diabetes, supplementation with Se in such diseases appears worthwhile. Another study showed a better effect with Se-methionine than with Na-selenate [127], confirming other data [128]. However no positive effect was found on diabetes prevention and some data even pointed towards an increased risk [132]. A cross-sectional study in almost 9000 american adults as well as another analysis reported a positive link between high Se levels and diabetes [133, 134]. Therefore, as is the case for use of high Se in cancer [135], caution applies to utilization of Se supplementation in diabetes, especially since quite high doses are required to observe beneficial effects [113, 129].
Mechanisms of action
Va is usually described as "insulin mimetic", in view of several in vitro experiments looking at insulin receptor signaling. An ex vivo study in Va-treated gerbils suggested that Va was potentiating, rather than mimicking, insulin and that the main action was on GLUT-4 trafficking [144]. This could explain its poor effects in insulin resistant, normoglycaemic states [145, 146]. many positive reports exist showing beneficial effects of various Va salts in mild or severe diabetes. Improvements in insulin-sensitivity were claimed to be due to a hepatic effect rather than to an improvement in peripheral insulin resistance [154]. Transient diabetes has been associated with Li withdrawal, pointing to the potential effect of this trace element [166].
Biological effects
In vitro Li increased both basal and insulin-stimulated glucose transport, as well as glycogen synthesis in soleus muscle of insulin resistant, obese Zucker rats [167]. The effect operated via increasing p38MAPKinase, confirming previous similar findings [168]. Another study showed paradoxical effects of oral Li in rat liver: while glycogen synthase was activated and glycogen phosphorylase was decreased, liver glycogen nevertheless decreased [170]. The global outcome in humans is somewhat frustrating in view of the logical good expectations from mechanistic effects of these metals at key steps of glucose and insulin regulatory control [171]. From existing data it appears that in prediabetic or diabetes, trace elements have no or little beneficial effect if the patients do not present deficiencies. Furthermore they could even induce aggravation of metabolic disorders, in line with known inversions of effects of antioxidants at supraphysiological doses. Alternatively the positive effects of micronutrient supplementation is only observed on surrogate parameters such as blood levels of mediators of inflammation and oxidative stress or indices of insulin sensitivity without accompanying improvement in glycaemic control.
-Some Info from (used: Open Text Summarizer [splitbrain.org])
Trace elements in bipolar disorder. - NCBI
Trace elements in bipolar disorder. - PubMed - NCBI
by M González-Estecha - 2011 - Cited by 33 - Related articles
Jan 15, 2011 - INTRODUCTION: Trace elements may play an important role in bipolar disorders. The objective of this study is to determine serum copper and
And some Diabetes Study which mentions Lithium (and says not generalizable... weakly effective for treating DIABETES). I don't have that... but whatever, BP may also be "a metabolistic disorder"
Trace elements in glucometabolic disorders: an update | Diabetology & Metabolic Syndrome | Full Text
Journal of Trace Elements in Medicine and Biology
Volume 25, Supplement 1, January 2011, Pages S78-S83
Abstract
Trace elements may play an important role in bipolar disorders. The objective of this study is to determine serum copper and zinc, blood lead and cadmium and urine lead, cadmium and thallium concentrations in patients diagnosed with bipolar disorders and to compare these levels with those of a healthy control group. There was a statistically significant increase (p = 0.001) in zinc levels among patients in the manic phase (mean 111.28, SD: 33.36 μg/dL) with respect to the control group (mean 86.07, SD: 12.39 μg/dL). 2010
Published: 19 December 2010
Abstract
Many trace elements, among which metals, are indispensable for proper functioning of a myriad of biochemical reactions, more particularly as enzyme cofactors. This is particularly true for the vast set of processes involved in regulation of glucose homeostasis, being it in glucose metabolism itself or in hormonal control, especially insulin. The role and importance of trace elements such as chromium, zinc, selenium, lithium and vanadium are much less evident and subjected to chronic debate. A careful survey of the literature shows that while theoretical postulates from some key roles of these elements had led to real hopes for therapy of insulin resistance and diabetes, the limited experience based on available data indicates that beneficial effects and use of most of them are subjected to caution, given the narrow window between safe and unsafe doses. Clear therapeutic benefit in these pathologies is presently doubtful but some data indicate that these metals may have a clinical interest in patients presenting deficiencies in individual metal levels.
Keywords
Insulin Resistance
Amyotrophic Lateral Sclerosis
Insulin Receptor
Prediabetic State
Phosphotyrosine Phosphatase
Introduction
Many trace elements, among which metals, involved as cofactors in myriads of biochemical-especially-enzymatic reactions. A good example to illustrate their important contribution is magnesium: low magnesium levels have been associated with increased type 2 diabetes [1, 2], whereas controversy exists about the importance of hypomagnesaemia in prediabetic states [3].
Trace elements have been identified for long time as potential candidates for improving metabolic disorders like prediabetes [insulin resistance, obesity, metabolic syndrome] or diabetes. In parallel with increasing comprehension of cellular and biochemical mechanisms leading to-or aggravating- these metabolic disorders, identifying the cellular targets and sites of action of trace elements has reactivated interest in their therapeutic potential. Activation of insulin receptor signalling (chromium), antioxidant properties (selenium, zinc) or inhibition of phosphatases (vanadium) thus appeared promising in view of the key importance of these processes in glucose homeostasis and insulin sensitivity. Indeed insulin receptor/postreceptor signalling defects are considered to underlie glycemic dysregulation and insulin resistance, although the precise causal defects must still be unravelled [4, 5]. Moreover, these mechanisms may be involved in concert in the pathogenesis of insulin resistance and accompanying pathologies [9].
The present review updates our actual state of knowledge about those five trace elements (chromium, zinc, selenium, vanadium, lithium)which have a therapeutic potential in insulin resistance and diabetes, describing their mechanisms of action and their efficacy in both animal and human investigations.
Chromium
General aspects
The importance of chromium (Cr) for glucose metabolic regulation has been seen in clinical states of relatively severe Cr deficiency, characterized by impaired glucose tolerance, fasting hyperglycaemia and eventually lipid disorders [10, 11]. Severe deficiencies are mostly limited to parenteral nutrition but analysis of diet plans currently in use in United States reveals a lack of Cr in many diets, potentially linked to various chronic diseases..
Mechanisms of action
Several mechanistic studies showed improvements in insulin receptor/postreceptor signalling, leading to increased glucose transport by enhanced activity of the hormone-sensitive GLUT-4 transporters. These effects can be due to the receptor itself, its control mechanisms or its immediate environment in the cell membrane. Cr-picolinate was shown to induce various effects: increase in AMPKinase and p38 MAPkinase activities [20], increase in receptor phosphorylation [21] and increase in insulin receptor mRNA (in addition to mRNA for GLUT-4, glycogen synthase and UCP3)[22]. Increased synthesis of IGF receptors, able to functionally replace failing insulin receptors, was also described [23]. Changes in the environment of insulin receptors were shown as reductions in plasma membrane cholesterol [24, 25], leading to improved cytoskeletal functioning and enhanced insulin sensitivity. Decreases in TNFα [26, 27], resistin [28], interleukin-6, CRP [27] as well as increases in vitamin C or adiponectin [29] were all positive mechanisms to reduce insulin resistance by Cr.
Finally, one should mention that Cr can bind directly to insulin, in particular to insulin dimers [30], thereby possibly stabilizing the hormone structure and/or modifying its receptor binding. Interestingly the Cr binding to insulin receptors occurs on a sequence of 3 aminoacids which are identical to those described for GTF decades ago (see below).
Biological effects
The appearance of glucose intolerance or even fasting hyperglycaemia in demonstrated cases of Cr deficiency have rapidly led to investigations on the potential of Cr supplementation in insulin resistance and diabetes. Furthermore, diabetic patients have about 1/3 less Cr in various biological samples [31, 32, 33]. While it was shown that inorganic Cr was poorly active, Mertz and coworkers identified as early as 1955 a complex found in brewer's yeast, liver and kidney which was able to stimulate glucose transport in the presence-but not in absence- of insulin and which contained Cr. Its activity required insulin and was dependent on its Cr content, ideally 4 ions/molecule, while 8 ions/molecule revealed toxic [34, 35]. Replacement of Cr by other metals did not reproduce GTF biological activity. It increased insulin efficacy in adipocytes [35, 37] at relatively high concentrations but no effects was found in diabetic patients despite demonstrable increases in Cr content of various tissues [38]. Especially in vitro and in animals studies are usually performed with irrelevant concentrations of the active compound, leading to so-called "pharmacological" effects. In vitro many beneficial effects of Cr salts have been reported for insulin resistance or diabetes; Cr chloride increased glucose transport in fat and muscle cells as well as in cardiomyocytes [17, 25, 35]. Insulin resistance improved in high fat/low Cr diet-fed rats [43], in sucrose-fed rats [44], in Zucker diabetic fatty rats [29], in GK rats [45, 46], in JCR-LA corpulent rats [47] and in db/db mice [48].
In addition to positive effects on glucose and insulin metabolic profiles, some studies also reported reduction in triglycerides [37] and stimulation of β-oxidation [50]. Positive reports with Cr exist in type2 diabetics treated with sulfonylureas [51] or in combination with either biotin [52] or vitamins C and E [53]. It is likely that patient selection is cardinal [57] and that Cr supplementation is primarily of interest in patients suffering from clearcut Cr deficiency if the aim is to reduce hyperglycaemia [58] or as an adjuvant to already-existing treatment with oral antidiabetics.
Based on mechanistic hypotheses (see below) the best application might be insulin resistance (prediabetes, metabolic syndrome), although this is also controversial: reduction in insulin resistance was observed in diabetics [53, 59] but also in obese women suffering polycystic ovary syndrome [60]. Another study in metabolic syndrome found no effect, however [61].
Zinc
General aspects
Zinc (Zn) is an essential micronutrient which has an important role in the functioning of hundreds of enzymes [62], in insulin metabolism and acts as an efficient antioxidant [63, 64]. Consequently many observations relate to Zn deficiency, although clinical signs of deficiency are quite modest. Because Zn has no storage form, there is need for a constant supply and Zn availability to cells is particularly well regulated, albeit poorly understood [67, 68]. Zn absorption can be reduced by iron or inflammatory bowel diseases. It is transported across cell membranes via t....
Severe Zn deficiency is not frequent but concerns have nevertheless been raised about Zn levels in diabetic patients because of increased excretion due to polyuria. Whereas some studies have reported Zn deficiency in type 2 diabetes [31, 76, 77, 78], others failed to find significant differences with healthy subjects [79, 80]. In type 1 diabetes, Zn deficiency is expected to increase the pancreatic damage [81]. A recent report described reduced levels of Zn in obese, insulin resistant subjects [82]. Lower Zn plasma concentrations were found in type 2 diabetics but they were not related to glycemic status or diabetes duration or components of the metabolic syndrome [83]. Interestingly it was reported that diabetic have elevated levels of copper [78, 80] and it could be that copper is in fact linked to metabolic syndrome and diabetes [80, 84]. Nevertheless, reduced Zn levels in diabetics appear to be related to increased risk for coronary artery disease [77] and mortality [85].
Mechanisms of action
Several modes of action have been described to explain the improved action of insulin by Zn. It appears that Zn can have direct insulin-like effects, which may be due to inhibition of the important glycogen-regulating enzyme GSK3 [86]. Zn can also reduce cytokines such as IL-1β as well as NFκB [87, 88]. Zn induces metallothionein synthesis, whereby Zn may have indirect efficacy [87]. Finally it has been suggested that the important Zn concentrations for its action are the intracellular -rather than plasma- levels [89]. Because Zn controls metallothionein expression it is involved in cellular redox regulation [91, 92]. Oxidative stress can be corrected by dietary Zn as demonstrated by an elevation of hepatic antioxidant enzymes [93].
Biological effects
Despite the potential interest in Zn in diabetes only some investigations have been published (reviewed in 62). In animals Zn prevented the development of type 1 diabetes induced by alloxan or streptozotocin [87]. In a study on Zn restriction during pregnancy in rats, offsprings presented reduced body weight, increased fat mass and low lean mass and showed reduced insulin response to glucose challenge. In db/db mice Zn reduced hyperglycaemia and hyperinsulinaemia [98]. Administration of Zn for 3 months reduced proteinuria [99]. Zn restriction increased oxidative stress and the levels of isoprostanes [100], in line with antioxidant effects of Zn. Excessive Zn, on the other hand, increased metabolic syndrome in rats fed a high fat/sucrose diet [101];
High Zn slightly reduced the risk for type 2 diabetes in a prospective study performed in 8300 women and the effect was limited to the Zn-deficient subgroup [103]. In microalbuminuric type 2 diabetic patients Zn lowered homocysteine levels while increasing vitamin B12 and folate levels [105]. In obese, non-diabetic subjects insulin sensitivity was improved without changes in leptin levels [106]. However no preventive effect against diabetes development could be found in obese women [107]. Oxidative stress was reduced by Zn in healthy elderly subjects [108]. It increases the pancreatic insulin content and improves the glucose tolerance test [109]. Its levels are lower in obese human subcutaneous and visceral adipose tissue and liver, but interestingly does not appear to be related to insulin resistance [110]. Severe Se deficiency is rare, while reduced Se levels are seen in diabetics together with increased oxidative stress. In offsprings of diabetic patients Se correlates inversely with CRP and with insulin resistance if Se levels are below 80 μg/l [118].
Biological effects
In view of the potent antioxidant [122, 123] and anti-inflammatory effects of Se and the prominent role played by these disorders in insulin resistance and diabetes, supplementation with Se in such diseases appears worthwhile. Another study showed a better effect with Se-methionine than with Na-selenate [127], confirming other data [128]. However no positive effect was found on diabetes prevention and some data even pointed towards an increased risk [132]. A cross-sectional study in almost 9000 american adults as well as another analysis reported a positive link between high Se levels and diabetes [133, 134]. Therefore, as is the case for use of high Se in cancer [135], caution applies to utilization of Se supplementation in diabetes, especially since quite high doses are required to observe beneficial effects [113, 129].
Mechanisms of action
Va is usually described as "insulin mimetic", in view of several in vitro experiments looking at insulin receptor signaling. An ex vivo study in Va-treated gerbils suggested that Va was potentiating, rather than mimicking, insulin and that the main action was on GLUT-4 trafficking [144]. This could explain its poor effects in insulin resistant, normoglycaemic states [145, 146]. many positive reports exist showing beneficial effects of various Va salts in mild or severe diabetes. Improvements in insulin-sensitivity were claimed to be due to a hepatic effect rather than to an improvement in peripheral insulin resistance [154]. Transient diabetes has been associated with Li withdrawal, pointing to the potential effect of this trace element [166].
Biological effects
In vitro Li increased both basal and insulin-stimulated glucose transport, as well as glycogen synthesis in soleus muscle of insulin resistant, obese Zucker rats [167]. The effect operated via increasing p38MAPKinase, confirming previous similar findings [168]. Another study showed paradoxical effects of oral Li in rat liver: while glycogen synthase was activated and glycogen phosphorylase was decreased, liver glycogen nevertheless decreased [170]. The global outcome in humans is somewhat frustrating in view of the logical good expectations from mechanistic effects of these metals at key steps of glucose and insulin regulatory control [171]. From existing data it appears that in prediabetic or diabetes, trace elements have no or little beneficial effect if the patients do not present deficiencies. Furthermore they could even induce aggravation of metabolic disorders, in line with known inversions of effects of antioxidants at supraphysiological doses. Alternatively the positive effects of micronutrient supplementation is only observed on surrogate parameters such as blood levels of mediators of inflammation and oxidative stress or indices of insulin sensitivity without accompanying improvement in glycaemic control.
Last edited: